nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxandrolone—AR—scrotum—testicular cancer	0.234	0.4	CbGeAlD
Oxandrolone—AR—seminiferous tubule of testis—testicular cancer	0.182	0.311	CbGeAlD
Oxandrolone—AR—semen—testicular cancer	0.101	0.172	CbGeAlD
Oxandrolone—Testicular atrophy—Chlorambucil—testicular cancer	0.0696	0.168	CcSEcCtD
Oxandrolone—Oligospermia—Ifosfamide—testicular cancer	0.0319	0.0769	CcSEcCtD
Oxandrolone—Azoospermia—Ifosfamide—testicular cancer	0.0248	0.0598	CcSEcCtD
Oxandrolone—Azoospermia—Cisplatin—testicular cancer	0.0214	0.0516	CcSEcCtD
Oxandrolone—AR—seminal vesicle—testicular cancer	0.0213	0.0365	CbGeAlD
Oxandrolone—AR—gonad—testicular cancer	0.0154	0.0263	CbGeAlD
Oxandrolone—Oligospermia—Methotrexate—testicular cancer	0.0151	0.0364	CcSEcCtD
Oxandrolone—Oligospermia—Epirubicin—testicular cancer	0.0141	0.034	CcSEcCtD
Oxandrolone—Oligospermia—Doxorubicin—testicular cancer	0.0131	0.0315	CcSEcCtD
Oxandrolone—AR—female gonad—testicular cancer	0.0125	0.0214	CbGeAlD
Oxandrolone—Bronchial hyperreactivity—Methotrexate—testicular cancer	0.0121	0.0292	CcSEcCtD
Oxandrolone—Azoospermia—Methotrexate—testicular cancer	0.0117	0.0283	CcSEcCtD
Oxandrolone—AR—testis—testicular cancer	0.0111	0.019	CbGeAlD
Oxandrolone—Chronic obstructive pulmonary disease—Methotrexate—testicular cancer	0.0111	0.0267	CcSEcCtD
Oxandrolone—Azoospermia—Epirubicin—testicular cancer	0.011	0.0265	CcSEcCtD
Oxandrolone—Azoospermia—Doxorubicin—testicular cancer	0.0102	0.0245	CcSEcCtD
Oxandrolone—Necrosis—Dactinomycin—testicular cancer	0.00929	0.0224	CcSEcCtD
Oxandrolone—Neoplasm—Chlorambucil—testicular cancer	0.00913	0.022	CcSEcCtD
Oxandrolone—Necrosis—Ifosfamide—testicular cancer	0.00851	0.0205	CcSEcCtD
Oxandrolone—Neoplasm—Vinblastine—testicular cancer	0.00837	0.0202	CcSEcCtD
Oxandrolone—AR—lymph node—testicular cancer	0.00806	0.0138	CbGeAlD
Oxandrolone—Necrosis—Cisplatin—testicular cancer	0.00734	0.0177	CcSEcCtD
Oxandrolone—Necrosis—Etoposide—testicular cancer	0.00672	0.0162	CcSEcCtD
Oxandrolone—Neoplasm—Ifosfamide—testicular cancer	0.00604	0.0146	CcSEcCtD
Oxandrolone—Fluid retention—Cisplatin—testicular cancer	0.00547	0.0132	CcSEcCtD
Oxandrolone—Haemoglobin—Vinblastine—testicular cancer	0.00467	0.0113	CcSEcCtD
Oxandrolone—Haemorrhage—Vinblastine—testicular cancer	0.00465	0.0112	CcSEcCtD
Oxandrolone—Blood creatinine increased—Ifosfamide—testicular cancer	0.00454	0.011	CcSEcCtD
Oxandrolone—Necrosis—Methotrexate—testicular cancer	0.00403	0.00971	CcSEcCtD
Oxandrolone—Irritability—Cisplatin—testicular cancer	0.00399	0.00962	CcSEcCtD
Oxandrolone—Haemoglobin—Bleomycin—testicular cancer	0.00395	0.00951	CcSEcCtD
Oxandrolone—Haemorrhage—Bleomycin—testicular cancer	0.00393	0.00947	CcSEcCtD
Oxandrolone—Blood creatinine increased—Cisplatin—testicular cancer	0.00392	0.00944	CcSEcCtD
Oxandrolone—Necrosis—Epirubicin—testicular cancer	0.00377	0.00909	CcSEcCtD
Oxandrolone—Necrosis—Doxorubicin—testicular cancer	0.00349	0.00841	CcSEcCtD
Oxandrolone—Haemoglobin—Ifosfamide—testicular cancer	0.00337	0.00813	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Epirubicin—testicular cancer	0.00337	0.00812	CcSEcCtD
Oxandrolone—Haemorrhage—Ifosfamide—testicular cancer	0.00336	0.00809	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Doxorubicin—testicular cancer	0.00312	0.00751	CcSEcCtD
Oxandrolone—Creatinine increased—Epirubicin—testicular cancer	0.00311	0.00749	CcSEcCtD
Oxandrolone—Creatinine increased—Doxorubicin—testicular cancer	0.00288	0.00693	CcSEcCtD
Oxandrolone—Neoplasm—Methotrexate—testicular cancer	0.00286	0.00689	CcSEcCtD
Oxandrolone—Gynaecomastia—Methotrexate—testicular cancer	0.00283	0.00682	CcSEcCtD
Oxandrolone—Fluid retention—Epirubicin—testicular cancer	0.00281	0.00677	CcSEcCtD
Oxandrolone—Oedema—Bleomycin—testicular cancer	0.00279	0.00672	CcSEcCtD
Oxandrolone—Neoplasm—Epirubicin—testicular cancer	0.00267	0.00645	CcSEcCtD
Oxandrolone—Oedema—Dactinomycin—testicular cancer	0.0026	0.00627	CcSEcCtD
Oxandrolone—Fluid retention—Doxorubicin—testicular cancer	0.0026	0.00626	CcSEcCtD
Oxandrolone—Neoplasm—Doxorubicin—testicular cancer	0.00248	0.00597	CcSEcCtD
Oxandrolone—Oedema—Ifosfamide—testicular cancer	0.00238	0.00575	CcSEcCtD
Oxandrolone—Irritability—Methotrexate—testicular cancer	0.00219	0.00528	CcSEcCtD
Oxandrolone—Oedema—Cisplatin—testicular cancer	0.00206	0.00495	CcSEcCtD
Oxandrolone—Blood creatinine increased—Epirubicin—testicular cancer	0.00201	0.00485	CcSEcCtD
Oxandrolone—Blood creatinine increased—Doxorubicin—testicular cancer	0.00186	0.00449	CcSEcCtD
Oxandrolone—Erectile dysfunction—Methotrexate—testicular cancer	0.00183	0.0044	CcSEcCtD
Oxandrolone—Haemoglobin—Methotrexate—testicular cancer	0.0016	0.00385	CcSEcCtD
Oxandrolone—Haemorrhage—Methotrexate—testicular cancer	0.00159	0.00383	CcSEcCtD
Oxandrolone—Haemoglobin—Epirubicin—testicular cancer	0.00149	0.0036	CcSEcCtD
Oxandrolone—Haemorrhage—Epirubicin—testicular cancer	0.00149	0.00358	CcSEcCtD
Oxandrolone—Haemoglobin—Doxorubicin—testicular cancer	0.00138	0.00333	CcSEcCtD
Oxandrolone—Haemorrhage—Doxorubicin—testicular cancer	0.00137	0.00331	CcSEcCtD
Oxandrolone—Oedema—Epirubicin—testicular cancer	0.00106	0.00254	CcSEcCtD
Oxandrolone—Insomnia—Methotrexate—testicular cancer	0.00102	0.00246	CcSEcCtD
Oxandrolone—Oedema—Doxorubicin—testicular cancer	0.000977	0.00235	CcSEcCtD
Oxandrolone—Insomnia—Epirubicin—testicular cancer	0.000955	0.0023	CcSEcCtD
Oxandrolone—Insomnia—Doxorubicin—testicular cancer	0.000883	0.00213	CcSEcCtD
